Search companies

Live

Tuesday, 17 November 2026 · 581 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Control Bionics Reports Revenue Growth, Reaffirms 50% FY27 Growth Outlook

CBL: $0.049 +0.00% · MC: $29M

Control Bionics said unaudited revenue rose each month in the September quarter and exceeded the June quarter, while it expects revenue growth of approximately 50% in FY27, weighted to the second half. Quarterly operating cash outflows included FY26 incentives and other one-off costs, with the company forecasting a material reduction in the next quarter; it reported cash at bank of approximately $6 million at quarter end and said its current plan funds operations through FY27 without another capital raising. Separately, it established a facility for eligible small shareholders to sell their holdings without brokerage or handling fees, with the company covering transaction costs.

Source announcements: 2026-10-29 08:14 to 2026-10-29 08:16 Sydney time
Story updated 2026-10-29 11:04 Sydney time
SourcesLess Than Marketable Parcel Sale FacilityQuarterly Activities/Appendix 4C Cash Flow Report
Comments